Loading…
Centuple Global (BSE 531099)₹31.98−0.84%Pharmaceuticals
In the Mar 2026 quarter (standalone), Centuple Global reported sales of ₹280 Cr, up 1,07,642.3% from Mar 2025, and net profit of −₹0.47 Cr, down 1,040.0% year on year. For the year to Mar 2026, sales were ₹575 Cr and net profit ₹1.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.21 | 0.30 | 0.18 | 0.48 | 0.11 | 0.06 | 0.11 | 0.26 | 11.75 | 109 | 175 | 280 |
| Expenses | 0.24 | 0.02 | 0.10 | 0.70 | 0.06 | 0.07 | 0.13 | 0.15 | 11.60 | 107 | 173 | 280 |
| Operating Profit | −0.04 | 0.25 | 0.05 | −0.23 | 0.02 | −0.02 | −0.03 | 0.08 | 0.08 | 1.79 | 0.76 | −0.36 |
| OPM % | −25.1% | 89.6% | 35.2% | −51.1% | 29.9% | −60.1% | −40.1% | 35.9% | 0.8% | 1.7% | 0.4% | −0.1% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | −0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.04 | 0.27 | 0.05 | −0.23 | 0.04 | −0.02 | −0.03 | 0.06 | 0.08 | 1.81 | 0.76 | −0.36 |
| Tax % | 0.0% | 0.0% | 0.0% | −4.2% | 0.0% | 33.3% | 0.0% | 0.0% | 0.0% | 26.1% | 25.9% | 27.0% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | −0.04 | 0.25 | 0.05 | −0.22 | 0.01 | −0.03 | −0.03 | 0.05 | 0.08 | 1.31 | 0.56 | −0.47 |
| EPS (Rs) | −0.10 | 0.49 | 0.12 | −0.43 | 0.05 | −0.08 | −0.05 | 0.12 | 0.17 | 2.42 | 1.05 | −0.89 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 2.01 | 1.01 | 1.01 | 0.00 | 2.01 | 1.01 | 1.01 | 0.00 | 575 | 576 |
| Expenses | 0.00 | 0.00 | 1.99 | 0.99 | 0.99 | 0.00 | 1.99 | 0.99 | 0.99 | 0.00 | 572 | 571 |
| Operating Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 2.27 |
| OPM % | −5.0% | 9.9% | −1.3% | −31.1% | 2.0% | 2.0% | −1.0% | −7.0% | 2.6% | 19.9% | 0.4% | 0.4% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 2.29 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 20.0% | 0.0% | 50.0% | 0.0% | −50.0% | 40.0% | 34.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.99 | 1.48 |
| EPS (Rs) | −0.03 | 0.06 | −0.30 | −0.03 | 0.06 | 0.03 | −0.08 | −0.16 | 0.06 | 0.06 | 2.77 | 2.75 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 | 4.99 |
| Reserves | −4.99 | −4.99 | −5.00 | −5.00 | −5.00 | −5.00 | −5.00 | −5.00 | −5.00 | −5.00 | −5.00 | 17.99 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.99 |
| Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 313 |
| Total Liabilities | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 343 |
| Fixed Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 343 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 |
| Trade receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.99 | 0.00 | 337 |
| Cash & equivalents | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | 0.00 | 0.00 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 343 |
| Mar 2021 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | 0.99 | — | — | −27.91 |
| Cash from investing activity | 0.00 | — | — | 0.00 |
| Cash from financing activity | 0.00 | — | — | 28.08 |
| Net cash flow | 0.99 | — | — | 0.00 |
| Capex | 0.00 | 0.00 | 0.00 | 0.01 |
| Free cash flow | 1.01 | — | — | −28.03 |
| CFO / OP % | 5,200.1% | — | — | −1,223.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | — | 35 | 23 | 53 | 178 | 106 | 163 | 121 | 134 | 228 | 211 | 214 |
| Inventory days | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | 0 |
| Days payable | — | — | — | — | — | — | — | — | — | — | — | 197 |
| Cash conversion cycle | — | 37 | 25 | 55 | 180 | 108 | 165 | 123 | 136 | 230 | 213 | 20 |
| Working capital days | — | 18 | −35 | 36 | 260 | 221 | 60 | 98 | 129 | 145 | 387 | 15 |
| ROCE % | −3.0% | −3.0% | 7.0% | 25.0% | −31.0% | 3.0% | 2.0% | −3.0% | −13.0% | 3.0% | 17.0% | 15.0% |
For the Mar 2026 quarter, Centuple Global reported sales of ₹280 Cr, up 1,07,642.3% year on year and net profit of −₹0.47 Cr, down 1,040.0% year on year. The operating margin was −0.1%.
Centuple Global's sales for the year to Mar 2026 were ₹575 Cr; over the last twelve months they were ₹576 Cr.
Net profit for the year to Mar 2026 was ₹1.99 Cr, and ₹1.48 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.75.
Centuple Global reported borrowings of ₹6.99 Cr at Mar 2026, against cash and equivalents of ₹0 Cr.
Cash from operations was −₹27.91 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹28.03 Cr.